Corrigendum to: Mitochondrial genome inheritance and replacement in the human germline (The EMBO Journal, (2017), 36, 15, (2177-2181), 10.15252/embj.201797606)

Don P. Wolf, Tomonari Hayama, Shoukhrat Mitalipov

Research output: Contribution to journalComment/debatepeer-review

6 Scopus citations

Abstract

The conflict of interest section contains information that is incorrect. The correct conflict of interest statement is as follows: Oregon Health & Science University has the patent entitled “Method for mitochondrial DNA replacement in oocytes”. SM is an inventor of the patent. SM is also a founder and CEO of Mitogenome Therapeutics, Inc. DPW and TH declare that they have no conflict of interest.

Original languageEnglish (US)
Pages (from-to)2659
Number of pages1
JournalEMBO Journal
Volume36
Issue number17
DOIs
StatePublished - Sep 1 2017

ASJC Scopus subject areas

  • General Neuroscience
  • Molecular Biology
  • General Biochemistry, Genetics and Molecular Biology
  • General Immunology and Microbiology

Fingerprint

Dive into the research topics of 'Corrigendum to: Mitochondrial genome inheritance and replacement in the human germline (The EMBO Journal, (2017), 36, 15, (2177-2181), 10.15252/embj.201797606)'. Together they form a unique fingerprint.

Cite this